SVP (Head), Clinical Development

Newly-created position to lead a transatlantic team planning and managing all assets starting in Phase II and taking them through pivotal trials, NDA/BLA submission, lifecycle management, and post-approval studies

Hematology-focused, fully-integrated, late-stage, well-funded public biotech

Multiple clinical-stage assets featuring wide variety of modality types

Clinical indications addressing rare, ultra-rare, and non-rare (mass market) diseases

Company intends to commercialize in US and globally

Report to a positive-minded, personable, and experienced CMO

Leadership team is highly regarded and has strong relevant TA experience with successful biotechs and pharmas

Boston metro area (3 days/week onsite)

SUMMARY: Cornerstone Search Group has been retained by a high-profile, fully-integrated, well-funded, public biotech with a multi-asset, late-stage pipeline for a newly-created SVP, Head of Clinical Development position. This biotech is focused on discovering, developing, and globally commercializing transformative therapies across a range of related rare, ultra-rare, and mass-market disorders that have long lacked meaningful treatment innovations. They have in development multiple first-in-class pipeline assets that utilize multiple small and large molecule modalities. They are now seeking an MD with strong industry late-stage clinical development and NDA/BLA submission experience who ideally has training or industry experience in Hematology, Hematology-Oncology, or Immunology.